A
Asita de Silva
Researcher at University of Kelaniya
Publications - 11
Citations - 125
Asita de Silva is an academic researcher from University of Kelaniya. The author has contributed to research in topics: Randomized controlled trial & Medicine. The author has an hindex of 6, co-authored 8 publications receiving 83 citations.
Papers
More filters
Journal ArticleDOI
Glyceryl Trinitrate for Acute Intracerebral Hemorrhage: Results From the Efficacy of Nitric Oxide in Stroke (ENOS) Trial, a Subgroup Analysis
Kailash Krishnan,Polly Scutt,Lisa J Woodhouse,Alessandro Adami,Jennifer L. Becker,Eivind Berge,Lesley Cala,Ana M. Casado,Valeria Caso,Christopher Chen,Hanna Christensen,Ronan Collins,Anna Członkowska,Robert A. Dineen,John Gommans,Panos Koumellis,Panos Koumellis,Panos Koumellis,Kennedy R. Lees,George Ntaios,Şerefnur Öztürk,Şerefnur Öztürk,Şerefnur Öztürk,Stephen J. Phillips,Stuart J. Pocock,Asita de Silva,Nikola Sprigg,Szabolcs Szatmári,Joanna M. Wardlaw,Philip M.W. Bath +29 more
TL;DR: In patients with intracerebral hemorrhage within 48 hours of onset, GTN lowered blood pressure was safe but did not improve functional outcome, and very early treatment might be beneficial but needs assessment in further studies.
Journal ArticleDOI
Control of blood pressure and risk attenuation: a public health intervention in rural Bangladesh, Pakistan, and Sri Lanka: feasibility trial results.
Tazeen H. Jafar,Asita de Silva,Aliya Naheed,Imtiaz Jehan,Feng Liang,Pryseley Nkouibert Assam,Helena Legido-Quigley,Eric A. Finkelstein,Shah Ebrahim,Rajitha Wickremasinghe,Dewan S. Alam,Aamir Hameed Khan +11 more
TL;DR: The proposed MCI is feasible for implementation and requires long-term, large-scale evaluation in the rural public health infrastructure in South Asian countries to determine sustainability of health system changes and BP control.
Journal ArticleDOI
Chinese Medicine NeuroAiD Efficacy Stroke Recovery - Extension Study (CHIMES-E Study): An Observational Multicenter Study to Investigate the Longer-Term Efficacy of NeuroAiD in Stroke Recovery
Narayanaswamy Venketasubramanian,Sherry Young,San San Tay,Hui Meng Chang,Thirugnanam Umapathi,Bernard P.L. Chan,Asita de Silva,Lawrence K.S. Wong,Jose C. Navarro,Yudong Zhao,Say Beng Tan,Christopher Chen +11 more
TL;DR: There are few acute treatments that reduce death and disability after stroke but there are a number of medications that can be helpful in the short and medium term.
Journal ArticleDOI
Budget impact and cost-effectiveness analyses of the COBRA-BPS multicomponent hypertension management programme in rural communities in Bangladesh, Pakistan, and Sri Lanka.
Eric A Finkelstein,Eric A Finkelstein,Anirudh Krishnan,Aliya Naheed,Imtiaz Jehan,H Asita de Silva,Mihir Gandhi,Ching Wee Lim,Nantu Chakma,Dileepa S Ediriweera,Jehanzeb Khan,Anuradhani Kasturiratne,Samina Hirani,A K M Solayman,Tazeen H. Jafar,Tazeen H. Jafar,Tazeen H. Jafar,Tazeen Hasan Jafar,Asita de Silva,Eric A. Finkelstein,Helena Legido-Quigley,Marcel Bilger,Liang Feng,Saeideh Tavajoh,Cecille Lintag,Pryseley Nkouibert Assam,Rajesh Babu Moorakanda,Xinyi Lin,Edwin Chan,Yiheng Zheng,John D. Clemens,Mohammad A. Hasnat,Chakma Nantu,Dewan S. Alam,Sonia Pervin,Ali Tanweer Siddiquee,Rubhana Rajib,Mohammad Tauhidul Islam,Akm Solayman,AamirHameed Khan,Sahar Senan,Hamid Farazdiq,Gulshan Himani,Syed Omair Nadeem,Hunaina Shahab,Ayesha Khan,Natasha Luke,Chamini K. De Silva,Manuja Perera,Channa D Ranasinha,Dileepa Senajith Ediriweera,Shah Ebrahim,Elizabeth L. Turner,Joep Perk,Richard Smith,Anne Mills,Elizabeth Allen,Kate Hunt,Jill Jones,Andrew Farmer,Doris Young,Bruce Neal,Say Beng Tan +62 more
Journal ArticleDOI
Association of Low-Dose Triple Combination Therapy With Therapeutic Inertia and Prescribing Patterns in Patients With Hypertension: A Secondary Analysis of the TRIUMPH Trial
Nelson Wang,Abdul Salam,Ruth Webster,Asita de Silva,Rama K Guggilla,Sandrine Stepien,Jayanthi Mysore,Laurent Billot,Stephen Jan,Pallab K. Maulik,Nitish Naik,Vanessa Selak,Simon Thom,Dorairaj Prabhakaran,Anushka Patel,Anthony Rodgers +15 more
TL;DR: Triple pill FDC therapy substantially simplified prescribing patterns and improved 6-month BP control rates compared with usual care, and further improvements in hypertension control could be achieved by addressing therapeutic inertia among the minority of patients who do not achieve BP control after initial FDC Therapy.